Silo Pharma, Inc.
SILO
$0.45
$0.011.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.23M | -5.08M | -4.90M | -4.62M | -4.39M |
| Total Depreciation and Amortization | 11.40K | 11.60K | 11.80K | 9.30K | 6.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 739.00K | 581.80K | 13.60K | -1.60K | 1.10K |
| Change in Net Operating Assets | -1.18M | -315.00K | -319.60K | -21.00K | 551.70K |
| Cash from Operations | -4.66M | -4.80M | -5.19M | -4.64M | -3.83M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 644.00K | 1.13M | 1.18M | 1.75M | 973.80K |
| Cash from Investing | 644.00K | 1.13M | 1.18M | 1.75M | 973.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.86M | 2.73M | 3.84M | 3.41M | 3.41M |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | -57.70K | -173.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.86M | 2.73M | 3.84M | 3.36M | 3.24M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 843.00K | -943.20K | -172.60K | 468.60K | 381.50K |